Explore how biomarker testing guides advanced non-small cell lung cancer (NSCLC) treatment, why treatment paths differ and change over time, and how research aims to address unmet needs and expand treatment options for lung cancer.

Tara Rowek, Senior Study Associate, explains how collaboration, attention to detail and patient-centered clinical research help maintain quality, strengthen clinical trials and advance potential new treatment options for patients.

Early breast cancer is often treated with curative intent—but there is still more to learn about treatment response and recurrence risk. Explore how researchers are following the science earlier in the disease journey to address unmet needs and advance new possibilities for patients.

Behind every medicine is a story—a story of people who make it possible. In the series Where Craft Meets, Daiichi Sankyo explores and celebrates the people behind our medicines and shares how our unique crafts contribute to our collective mission to help patients.

Cancer care is never carried out by one person alone. It is a team effort, with oncologists, nurses, pharmacists, pathologists, patient support teams, caregivers, and many others all supporting the patient.

I had no idea what to expect when I was deployed to Ground Zero. In moments like that, you do not hesitate, you jump into action. You do everything you can to help reconnect families.